Mechanism
Interferon-alpha2 (myeloid-specific expression)
Assets acting on this target.
- Class
- Gene therapy (lentiviral vector delivering interferon-alpha2 to myeloid cells)
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/study/NCT03866109